Status:
TERMINATED
eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies how to improve the diet quality and physical activity level of Latino cancer survivors living in rural areas. The recommendation to eat a high-quality diet and engage in mo...
Detailed Description
OUTLINE: Patients attend 6 online nutrition and physical activity (PA) education classes, cooking sessions, and participate in physical activities over 120 minutes each. Patients also receive text me...
Eligibility Criteria
Inclusion
- Participants must self-identify as being at least 18 years of age or older
- Participants must self-identify as Latino
- Participants must be a resident of the Lower Yakima Valley (LYV) and anticipate remaining in the LYV for at least 1 year
- Participants must speak Spanish or English and fully understand Spanish for online group sessions
- Participants must self-identify as having a medical history of hypertension
- Participants must self-identify as having a medical history of diabetes
- Participants must self-identify as having a medical history of cardiovascular disease
- Participants must self-identify as having a medical history of obesity, as defined by a body mass index (BMI) of \> 30 kg/m\^2
- Participants must self-identify as having a medical history of cancer (excluding non-melanoma skin cancer). All other cancer types will be included provided
- There is no evidence of recurrent or metastatic disease
- The patient has not received a bone marrow, stem cell, or cord blood transplant
- For cancer survivors, participants must self-identify as being at least 60 days post final chemotherapy, biologic therapy, or radiation therapy treatment and/or surgery. Current use of hormonal therapy is permitted (e.g., tamoxifen and aromatase inhibitors)
- Participants must be willing and able to receive text messages via cellphone for 3-6 months
- Participants must be willing and able to attend six 120-minute online group sessions
- Participants must be willing to complete the surveys, and diet/PA assessments
- Participants who report having been told by a health professional they have diabetes or cardiovascular disease must provide a clearance from their physician for participation
- Participants must consume \< 5 servings of fruits and vegetables per day and/or engage in \< 150 minutes per week of moderate to vigorous physical activity, as assessed by brief questionnaires
- Participants must have an Eastern Cooperative Oncology Group (ECOG) scale of performance status score of 0 or 1 for performance status. These scales and criteria are commonly used by doctors and trained research staff to assess a person's daily living abilities. These scales and criteria are commonly used by doctors and trained research staff to assess a person's daily living abilities. Scores of 0 and 1 corresponds to being fully active, able to carry on all pre-disease performance without restriction; and restricted in physically strenuous activity but ambulatory and able to carry our work of a light or sedentary nature, respectively
- Ability to understand and the willingness to sign an online informed consent document \* Depending on preference, the consent will be provided in English or Spanish
Exclusion
- Participants must not be active smokers within the past 30 days. Active smoking is defined as any smoking, even a puff. Participants who smoke are much less likely to engage in healthy lifestyle behaviors, and it is probably more important for participants to stop smoking than it is to change their dietary patterns. If identified as a smoker, the individual will be referred the Centers for Disease Control and Prevention (CDC) "Quit Now" phone line which supports smoking cessation, or the National Institutes of Health (NIH) quit support website SmokeFree.gov which are both available in English and Spanish
- Women must not be pregnant at time of enrollment
Key Trial Info
Start Date :
September 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 25 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04081298
Start Date
September 16 2021
End Date
February 25 2022
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109